- Home
- SGMT vs RMMZ Comparison
SGMT vs RMMZ Comparison
Compare SGMT & RMMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- RMMZ
- Stock Information
- Founded
- SGMT 2006
- RMMZ 2022
- Country
- SGMT United States
- RMMZ United States
- Employees
- SGMT N/A
- RMMZ N/A
- Industry
- SGMT
- RMMZ Investment Managers
- Sector
- SGMT
- RMMZ Finance
- Exchange
- SGMT Nasdaq
- RMMZ Nasdaq
- Market Cap
- SGMT 165.4M
- RMMZ 133.6M
- IPO Year
- SGMT 2023
- RMMZ N/A
- Fundamental
- Price
- SGMT $4.12
- RMMZ $15.82
- Analyst Decision
- SGMT Strong Buy
- RMMZ
- Analyst Count
- SGMT 7
- RMMZ 0
- Target Price
- SGMT $25.71
- RMMZ N/A
- AVG Volume (30 Days)
- SGMT 864.8K
- RMMZ 25.6K
- Earning Date
- SGMT 03-24-2025
- RMMZ 01-01-0001
- Dividend Yield
- SGMT N/A
- RMMZ 7.33%
- EPS Growth
- SGMT N/A
- RMMZ N/A
- EPS
- SGMT N/A
- RMMZ 0.82
- Revenue
- SGMT N/A
- RMMZ N/A
- Revenue This Year
- SGMT N/A
- RMMZ N/A
- Revenue Next Year
- SGMT N/A
- RMMZ N/A
- P/E Ratio
- SGMT N/A
- RMMZ $19.41
- Revenue Growth
- SGMT N/A
- RMMZ N/A
- 52 Week Low
- SGMT $2.39
- RMMZ $12.92
- 52 Week High
- SGMT $7.64
- RMMZ $16.99
- Technical
- Relative Strength Index (RSI)
- SGMT 43.11
- RMMZ 52.60
- Support Level
- SGMT $3.96
- RMMZ $15.71
- Resistance Level
- SGMT $4.83
- RMMZ $16.29
- Average True Range (ATR)
- SGMT 0.38
- RMMZ 0.18
- MACD
- SGMT -0.04
- RMMZ -0.04
- Stochastic Oscillator
- SGMT 13.39
- RMMZ 14.92
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).
About RMMZ RiverNorth Managed Duration Municipal Income Fund II Inc.
RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.